RLMD

Relmada Therapeutics is a clinical-stage biotechnology company developing novel medicines for the treatment of central nervous system diseases. The company is focused on developing esmethadone, a new chemical entity targeting treatment-resistant depression and other psychiatric conditions. Relmada uses its expertise in opioid receptor pharmacology to create non-addictive therapeutic candidates.